Constellation Capital Corp. is a Canada-based capital pool company. The principal business of the Company is to identify and evaluate assets or businesses with a view to acquire them or an interest therein by completing a purchase transaction.

Employees

Sector

Investment Holding Companies

More about the company

Market Closed - Toronto S.E. 11:00:00 2026-01-21 EST			5-day change	1st Jan Change
0.0700 ^CAD	-.--%		-.--%	-

07-27	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	476K 344K 295K 276K 252K 32.95M 481K 3.26M 1.27M 16.55M 1.29M 1.26M 54.75M	P/E 2024	-7.49x	P/E 2025	-8.26x
Enterprise Value	-150K -109K -93.09K -87.08K -79.61K -10.4M -152K -1.03M -401K -5.22M -408K -399K -17.28M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	90.67%	Yield 2024 *	-	Yield 2025	-

07-27	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-08	Active Witness Corp. entered into letter of intent to acquire Constellation Capital Corp. (TSXV:CNST.P) in a reverse merger transaction for CAD 16.4 million.	CI
01-29	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-11	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-07-15	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-04-23	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-01-23	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-01-16	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
25-01-16	300,000 Stock Options of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
24-10-30	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-07-22	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-07-19	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 20-JUL-2024.	CI

04-02	Constellation Announces Extension to Amalgamation Agreement with Active Witness Corp.	AQ
02-09	Constellation Announces Proposed Acquisition of Active Witness Corp.	AQ
11-14	Constellation Announces Extension Of LOI For The Proposed Acquisition Of Active Witness Corp.	AQ
25-09-29	Constellation Announces Proposed Acquisition Of Active Witness Corp.	AQ
25-09-29	Canadian Investment Regulatory Organization Trading Halt - CNST.P	AQ

Constellation Capital Corp. Stock

Stocks

CNST.P

CA21036W1032

Investment Holding Companies

Valuation: Constellation Capital Corp.

Chart: Constellation Capital Corp.

Latest news : Constellation Capital Corp.

Press Releases: Constellation Capital Corp.

Course Extremes

Managers and Directors: Constellation Capital Corp.

Latest insider transactions

Shell Companies

Financials

Company Profile

1 year	0.07	0.15
3 years	0.04	0.15
5 years	0.04	0.15
10 years	0.04	0.15

Director	Title	Age	Since
Dayton Marks BRD	Director/Board Member	33	2022-07-26
Roger Jewett BRD	Director/Board Member	63	2021-12-31
Robert Quinn BRD	Director/Board Member	70	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
12/10/24	Roger Jewett	Buy	Director	10,000	0.1471%
12/5/24	Roger Jewett	Buy	Director	50,000	0.7353%
12/5/24	Roger Jewett	Buy	Director	60,000	0.8824%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONSTELLATION CAPITAL CORP.	-.--%	-.--%	-36.36%	-22.22%	346K
CHURCHILL CAPITAL CORP XI	-3.29%	-18.08%	-	-	812M
CENTIEL AG	-7.74%	-12.61%	+279.62%	-76.16%	658M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	+0.20%	-	-	646M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.39%	+0.68%	-	-	600M
CHURCHILL CAPITAL CORP XII	+0.19%	-0.19%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	+0.44%	+0.34%	+2.47%	-	591M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-1.11%	-0.35%	-	-	578M
CHURCHILL CAPITAL CORP XIII	+0.10%	+0.10%	-	-	508M
Average	-1.21%	-2.74%	+81.91%	-49.19%	554.18M
Weighted average by Cap.	-1.54%	-3.82%	+148.40%	-76.13%

	2024	2025
Net sales	-	-
Net income	-45.38K -32.81K -28.12K -26.3K -24.05K -3.14M -45.86K -311K -121K -1.58M -123K -121K -5.22M	-57.62K -41.66K -35.7K -33.4K -30.53K -3.99M -58.23K -395K -154K -2M -156K -153K -6.63M
Net Debt	-679K -491K -421K -393K -360K -46.99M -686K -4.66M -1.81M -23.6M -1.84M -1.8M -78.07M	-626K -453K -388K -363K -332K -43.35M -633K -4.3M -1.67M -21.77M -1.7M -1.66M -72.02M